1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 43 Hits
  • Search Condition : Filter (MeSH = Liver Neoplasms / genetics*)
Species Resource
DNA material Transforming growth factor beta receptor type IIB (RDB01606) Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays.
DNA material anonymous clones alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis.
DNA material pEF-BOSneoSE-mNotch2 RAMIC (RDB06772) NOTCH2 signaling confers immature morphology and aggressiveness in human hepatocellular carcinoma cells.
Human and Animal Cells HuCCT1(RCB1960) Dysregulated Expression of MITF in Subsets of Hepatocellular Carcinoma and Cholangiocarcinoma.
Human and Animal Cells Hep G2(RCB1886) Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
Human and Animal Cells Hepa 1-6(RCB1638) The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
Human and Animal Cells Antitumor effects in hepatocarcinoma of isoform-selective inhibition of HDAC2.
Human and Animal Cells ANGPTL2 promotes tumor metastasis in hepatocellular carcinoma.
Human and Animal Cells Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
Human and Animal Cells HuH-7(RCB1942) LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells.
Human and Animal Cells Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.
Human and Animal Cells Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.
Human and Animal Cells LIFR functions as a metastasis suppressor in hepatocellular carcinoma by negatively regulating phosphoinositide 3-kinase/AKT pathway.
Human and Animal Cells Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.
Human and Animal Cells HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.
Human and Animal Cells Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma.
Human and Animal Cells MiR-376c down-regulation accelerates EGF-dependent migration by targeting GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line.
Human and Animal Cells Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
Human and Animal Cells miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.
Human and Animal Cells Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.